CompletedNot Applicable

Therapeutic Effects of Endoscopic Ablation of Hunner Lesions in Interstitial Cystitis/ Bladder Pain Syndrome Patients

South Korea442 participantsStarted 2012-08-01

Plain-language summary

efficacy of endoscopic ablation of Hunner lesions in patients with IC/BPS and the characteristics of HLs based on a long-term follow-up

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Male and female aged 18 yrs or greater
✓. Patients diagnosed with BPS(Bladder Pain Syndrome)
✓. Symptom persisted more than 6 months
✓. Pain VAS ≥4
✓. O'Leary-Sant Interstitial Cystitis questionnaire (IC-Q) scores 12 or greater with pain and nocturia domain scores \> 2.
✓. Pelvic Pain and Urgency/Frequency Patient Symptom Scale(PUF) \>13
✓. No history of cystoscopy within 2yrs.

✕. History of augmentation cystoplasty or previous transurethral coagulation/resection due to BPS
✕. Child-bearing potential, pregnant or nursing women.
✕. Mean voided volume lesser than 40ml or over than 400ml.
✕. Hematuria exceeds 1+ in the urinary dipstick (dipstick) examination.
✕. Urinary tract infection during run-in periods.
✕. Genitourinary tuberculosis or bladder,urethral and prostate cancer
✕. Recurrent urinary tract infection
✕. History of hysterectomy,mid-urethral sling,pelvic organ prolapse repair,vaginal delivery or Cesarean section,prostate operation or treatment etc within 6months.

change in recurrence-free survival time after ablation treatment

Timeframe: Every three months for one year

NCT IDNCT03468530

SponsorSamsung Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2013-12-31